2019-05-06| Asia-Pacific

Plenary Speaker – Jeff Karp

by GeneOnline
Share To

” We are excited to announce that Jeff Karp of Harvard Medical School & MIT will join us for the Plenary Session. A brilliant researcher and compelling speaker, Jeff was recognized as one of the top innovators under the age of 35, received both the Young Investigator award from the Society for Biomaterials, and the Champion in Health Care Innovation. Jeff was a speaker at the TED Talk on Radical Simplicity, and the TED Talk on Bio. “
  • Judy Chou, SVP & Global Head of Biotech, Bayer
  • Samantha Du, Chairman and CEO, Zai Lab, China
  • James C. Greenwood, President, and CEO, Biotechnology Innovation Organization (BIO)
  • Iduru Kokubu, Head of Healthcare Solutions UnitⅡ, Fujitsu
  • Heidi H. Kong, Investigator, Dermatology Branch/NIAMS, NIH
  • Rajiv Rana, Head of Medical Affairs APAC, Merck
  • Josh Rose, Vice President, Global Head of Strategy, IQVIA
  • Yi Shi, Managing Director, Lilly Asia Ventures
  • Simranjit Singh, CEO Asia, Middle East & Africa, Guardant Healthcare
  • Jarret C.J. Su, Head of Healthcare, KPMG
  • Sam Thong, Managing Director, Morgan Stanley Hong Kong
  • Ethan Tu, Founder, Taiwan AI Labs
  • Chii-Wann Lin, Vice President, and General Director, Industrial Technology Research Institute
  • Timothy Lu, Associate Professor, MIT
  • Michael McManus, Professor, UC San Francisco
  • Masayuki Nomura, International Affairs Committee, Forum for Innovative Regenerative Medicine (FIRM)
  • Talor Sax, CEO, eHealth Ventures
  • Markus Bauss, Managing director, SHL group
  • You-Tzung Chen, Associate Professor, National Taiwan University
  • Atsushi Hasuoka, APAC DAEWG
  • Robert Hofmeister, Chief Scientific Officer, TCR2 Therapeutics
  • Yoichiro Hamazaki, Deputy Senior General Manager, INFOCOM CORPORATION
  • Jeff Karp, Professor of Medicine, Harvard Medical School & MIT
  • Chien-Tsun Kuan, EVP/ COO & CTO, GenomeFrontier Therapeutics
  • Kazem Kazempour, President & CEO, Amarex Clinical Research
  • Rongjin Lin, Chairman, Center Laboratories Group
  • Fu-Tong, Liu, Vice Preside Director Division of Translational Research, Academia Sinica
  • Scott Liu, President, and CEO, Henlius Biotech
  • Kim Nearing, Managing Director, Cedrus Investments
  • Chung-Kang Peng, Professor, Harvard University
  • Victor Shi, Chairman, BayHelix Group
  • Jim Tsao, Chairman, and Head of China, Permira Private Equity Fund
  • Jonas Wang, Chairman & CEO, Stemcyte
  • Chun-Ying Wu, Director, Division of Translational Research, Taipei Veterans General Hospital
  • Yao Yi, CEO, BioCeltech
  • Alice Lin-Tsing Yu, Distinguished Chair Professor, Chang Gung University
  • Guo-Liang Yu, CEO, Apollomics
© All rights reserved. Collaborate with us:
Related Post
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
Company Presentations at BIO 2024 Inspire Partnering
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
BIO Releases DEI Survey in Partnership with Korn Ferry
Scroll to Top